Gainers Tenon Medical (NASDAQ:TNON) stock rose 122.5% to $12.13 during Wednesday's pre-market s

Gainers Tenon Medical (NASDAQ:TNON) shares moved upwards by 70.3% to $9.28 during Tuesday's aft

Follows recent European patent grant and coverage in multiple international markets as Silo continue

Follows recent European patent grant and coverage in multiple international markets as Silo continue

Gainers Bone Biologics (NASDAQ:BBLG) stock moved upwards by 17.7% to $1.07 during Wednesday's p

Patent strengthens global IP protection for novel treatment approach designed to prevent stress-indu

Gainers AbCellera Biologics (NASDAQ:ABCL) shares increased by 8.2% to $7.5 during Friday's afte

Collaboration supports development of a next-generation AWS-native platform designed to accelerate c

Collaboration supports development of a next-generation AWS-native platform designed to accelerate c

Silo Pharma, Inc. (NASDAQ: SILO - Get Free Report) was the recipient of a large increase in short in

Silo continues to add technology assets as it expands its AI business and further develops its lead

Silo Pharma Incs (NASDAQ:SILO) announced on Tuesday that its wholly owned subsidiary, QwikAgents, ha

Silo Pharma's QwikAgents joins AMD's AI Developer Program, gaining cloud credits and tools t

Silo Pharma (NASDAQ:SILO) ("Silo" or "the Company"), a diversified developmental-sta

SARASOTA, FLA. , July 14, 2026 (GLOBE NEWSWIRE) -- Silo Pharma (Nasdaq: SILO) ("Silo" or "the Compan

Apple partners with Broadcom on a multiyear agreement exceeding $30 billion to develop custom silico

Gainers EUDA Health Holdings (NASDAQ:EUDA) shares rose 22.3% to $15.2 during Friday's regular s

Gainers VYNE Therapeutics (NASDAQ:VYNE) stock increased by 17.9% to $0.79 during Friday's pre-m

$4 million upfront with up to approximately $7.7 million of potential additional gross proceeds upon

NVIDIA Corp. (NASDAQ:NVDA) expanded its presence in life sciences AI through separate initiatives wi

Nvidia expands its life sciences AI ecosystem through a Certara partnership and QwikAgents' entr

Silo Pharma (NASDAQ:SILO) ("Silo" or "the Company"), a diversified developmental-sta

NVIDIA developer program resources expected to support autonomous AI agent innovation and marketing

Silo Pharma (NASDAQ:SILO) ("Silo" or "the Company"), a diversified developmental-sta

Study designed to evaluate performance and formulation stability of proprietary nose-to-brain delive

Positive data supports the continued advancement of FDA Investigational New Drug (IND)- enabling dev

Positive data supports the continued advancement of FDA Investigational New Drug (IND)- enabling dev

SARASOTA, FLA., June 18, 2026 (GLOBE NEWSWIRE) -- Silo Pharma (Nasdaq: SILO) (“Silo” or “the Company

SILO Pharma (NASDAQ:SILO) reported quarterly losses of $(0.12) per share. This is a 47.83 percent in

New initiative from Silo Pharma designed to align with federal actions to accelerate mental health i

New initiative from Silo Pharma designed to align with federal actions to accelerate mental health i

Federal initiatives focused on PTSD and related conditions appears to validate need for new and nove

Silo Pharma, Inc. (NASDAQ: SILO - Get Free Report) was the target of a significant growth in short i

SPC-15 Intranasal PTSD Program Aligns with Federal Push to Fast-Track Novel Mental Health TherapiesS

Silo Pharma shares are trading higher Tuesday after the EPO signaled intent to grant a patent for it

(Editor’s note: The future prices of benchmark tracking ETFs, the lede, the economic data and the he

SILO stock rose 51.8% in pre-market trading after its PTSD treatment pipeline received a patent from

U.S. stock futures down, investors should watch Levi Strauss, Silo Pharma, Greenbrier, Mach Natural

Silo Pharma stock jumps after-hours after European patent allowance for PTSD prevention therapy targ